NCT01974440 2025-05-25SELENEJanssen Research & Development, LLCPhase 3 Completed403 enrolled 23 charts
NCT05934097 2023-07-06FT596 in Combination With R-CHOP in Subjects With B-Cell LymphomaFate TherapeuticsPhase 1 Withdrawn